摘要
动脉粥样硬化(AS)是缺血性心脑血管疾病的最重要病理学基础。近年来,以降脂为核心的控制危险因素的治疗大大降低并延缓了As的发生,但却未能完全阻断其进展,As性疾病在未来数年内仍然是发病率和死亡率最高的疾病。
出处
《中华心血管病杂志》
CAS
CSCD
北大核心
2012年第5期442-445,共4页
Chinese Journal of Cardiology
参考文献38
-
1Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol, 2006,6:508-519.
-
2Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005,352 : 1685-1695.
-
3姚康,葛均波,孙爱军,洪晓武,施鸿毓,黄榕翀,贾庆哲,王克强,钟翠平,曹雪涛,邹云增.高糖对人单核细胞源树突状细胞分化成熟和免疫功能的影响及其机制研究[J].中华心血管病杂志,2006,34(1):60-64. 被引量:18
-
4Gurfinkel E, Lernoud V. The role of infection and immunity in atherosclerosis. Expert Rev Cardiovasc Ther, 2006,4 : 131-137. Stassen FR, Vainas T, Bruggeman CA. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep,2008 ,60 :85-92.
-
5Stassen FR, Vainas T, Bruggeman CA. Infection and atherosclerosis. An ahemative view on an outdated hypothesis. Pharmacol Rep ,2005,60:85-92.
-
6Shaw PX, Horkko S, Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest, 2000,105 : 1731-1740.
-
7Tsimikas S, Brilakis ES, Lennon RJ, et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res, 2007,48:425-433.
-
8Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A, 1995, 92:821-825.
-
9Freigang S, Horkko S, Miller E, et al. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atheroselerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioseler Thromb Vase Biol, 1998,18 : 1972-1982.
-
10Zhou X, Caligiuri G, Hamsten A, et al. LDL immunizationinduces t-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol, 2001,21 : 108- 114.
二级参考文献12
-
1贾庆哲,葛均波,梁春,罗育坤,黄东,王克强,陈灏珠.糖基化终产物对人单核细胞源树突状细胞清道夫受体A表达的影响及其机制的研究[J].中华心血管病杂志,2004,32(10):888-892. 被引量:9
-
2Ross IL Atherosclerosis--an inflammatory disease. N Engl J Med,1999,340:115-126.
-
3Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of athemsclerosis. Circ Res, 2002,91 :281-291.
-
4Bobryshev YV, Lord RS. Mapping of vascular dendritic cells in atherescleretic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res, 1998,37:799-810.
-
5Ge J, Jia Q, Liang C, et al. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol, 2005,25:2157-2163.
-
6Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes, 1999,48:937-942.
-
7Wick G, Perschinka H, Millonig G. Atherescleresis as an autoimmune disease: an update. Trends Immunol, 2001,22: 665-669.
-
8Aicher A, Heeschen C, Mohaupt M, et al. Nicotine strongly activates dendritic cell-mediated adaptive immunity : potential role for progression of atherosclerotic lesions. Circulation, 2003, 107: 604-611.
-
9Alderman CJ, Bunyard PR, Chain BM, et al. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res,2002,55:806-819.
-
10Michael B. Biochemistry and molecular cell biology of diabetic complication. Nature, 2001, 414:813-817.
共引文献17
-
1王钢,夏冰.树突状细胞在动脉粥样硬化病程中的病理意义[J].心血管康复医学杂志,2007,16(2):198-200. 被引量:2
-
2胡炎伟,唐朝克,Jim Xiang.树突状细胞在动脉粥样硬化发生发展中的作用[J].中国动脉硬化杂志,2007,15(6):476-478. 被引量:3
-
3由倍安,高海青.树突状细胞在动脉粥样硬化免疫反应中的作用[J].中华心血管病杂志,2007,35(10):972-974. 被引量:2
-
4罗莹,夏宁.树突状细胞在1型糖尿病的发病机理与治疗中的作用[J].广西医科大学学报,2007,24(5):816-818. 被引量:1
-
5陆浩,钱菊英,姚康,孙爱军,黄榕翀,郝颖,施鸿毓,王克强,邹云增,葛均波.高浓度胰岛素对树突状细胞分化成熟及免疫功能的影响[J].中华心血管病杂志,2007,35(12):1151-1154. 被引量:1
-
6蒋波,张晓膺,罗光华,郑璐,Peter Nilsson-Ehle,徐宁.高血糖抑制大鼠载脂蛋白M的表达和分泌[J].苏州大学学报(医学版),2009,29(2):240-242.
-
7吕丰收,赵明耀,蒋莉莉,路静,黄幼田,杨洪艳,郑智敏,董子明.人直肠癌组织匀浆上清液对树突状细胞内皮化的影响[J].郑州大学学报(医学版),2010,45(3):413-416. 被引量:1
-
8叶双樱,陈礼平.树突状细胞介导的免疫反应在动脉粥样硬化中的作用[J].临床荟萃,2010,25(23):2114-2116. 被引量:2
-
9刘红樱,葛均波,马晓娟,史大卓.人参皂苷Rb_1对氧化型低密度脂蛋白诱导的人单核细胞源树突状细胞免疫成熟的影响[J].中国中西医结合杂志,2011,31(3):350-354. 被引量:6
-
10姚康,陆浩,张春瑜,吴彦,葛雷,钱菊英,邹云增,葛均波.急性冠状动脉综合征患者Fractalkine水平的研究[J].中国介入心脏病学杂志,2012,20(4):181-184. 被引量:4
同被引文献26
-
1秦玲,张淑琴,张家颖.阿托伐他汀对家兔动脉粥样硬化血管细胞粘附分子-1基因表达的影响[J].中风与神经疾病杂志,2005,22(4):300-302. 被引量:5
-
2Skal6n K, Gustafsson M, Rydberg EK, et al. Subendothelial re- tention of atherogenic lipoproteins in early atherosclerosis[J]. Na- ture, 2002,417 (6890) : 750-754.
-
3Hegland O, Dickstein K, Larsen JP. Effect of simvastatin in pre- venting progression of carotid artery stenosis [J]. Am J Cardiol, 2001,87 (5) :643-645.
-
4Serruys PW, Garcfa-Garc a HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A (2) inhibitor dara- pladib on human coronary atherosclerotic plaque[J]. Circulation, 2008,118(11) : 1172- 1182.
-
5Tardif JC, L' allier PL, Ibrahim R, et al. Treatment with 5-1ipoxy- genase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome [J]. Circ Cardiovasc Imaging, 2010,3 (3) : 298-307.
-
6kkonen HM, Vahakangas E, Marr RA, et al. Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy[J]. Mol Ther, 2004,9 (4) : 548 -556.
-
7Oka K,Pastore L, Kim IH, et al. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-de- pendent adenoviral vector expressing the very low-density lipo- protein receptor[J]. Circulation,2001,103(9) : 1274-1281.
-
8Brousseau ME, Kauffman RD, Herderick EE, et al. LCAT modu- lates atherogenic plasma lipoproteins and the extent of athero- sclerosis only in the presence of normal LDL receptors in trans- genic rabbits [J]. Arterioscler Thromb Vasc Biol, 2000,20 (2) : 450-458.
-
9Li B,Zhang J, Li Z, et al. Adeno-associated virus serotype 2 me- diated transduction and coexpression of the human apoAI and SR-BI gene in HeopG2 cells[J]. Mol Biol Rep,2012,39 (1):25- 32.
-
10Lippi G, Favaloro EJ. Antisense therapy in the treatment of hy- percholesterolemia[J]. Eur J Intern Med,2011,22 (6) :541-546.
二级引证文献6
-
1王瑞,由天辉,黄竹航,赵新华.个体化延续护理干预对动脉粥样硬化患者服药依从性的影响[J].国际医药卫生导报,2014,20(13):1856-1860. 被引量:12
-
2康攀攀,姚树桐,周健,秦树存.糖化白蛋白在动脉粥样硬化发生发展中的作用[J].中国动脉硬化杂志,2018,26(11):1165-1169. 被引量:5
-
3王文进,毛亚锦.颈动脉粥样硬化与老年性头痛的相关性分析[J].检验医学与临床,2014,11(17):2373-2374. 被引量:2
-
4李娜,张新庄,王俨如,曹亮,丁岗,王振中,萧伟,徐筱杰.基于网络药理学方法探讨通塞脉片治疗动脉粥样硬化的作用机制[J].中国中药杂志,2016,41(9):1706-1712. 被引量:18
-
5李梅,赵雪芹,王同兆,王磊.动脉粥样硬化的发病机制及治疗的综述[J].科技视界,2017(26):35-36. 被引量:7
-
6王文栋,常晓彤,杜华阳.动脉粥样硬化易感基因挖掘与生物信息学分析[J].中国老年学杂志,2017,37(24):6071-6075. 被引量:2
-
1殷霄,文波,谭文杰.增强丙型肝炎病毒DNA疫苗免疫原性的策略[J].临床肝胆病杂志,2011,27(1):32-35.
-
2HIV/AIDS(爱滋病)的研究进展[J].医药与保健,2000,8(1):56-56.
-
3吴朝栋,陶其敏.丙型病毒性肝炎实验性疫苗研究进展[J].中华传染病杂志,1999,17(2):142-144. 被引量:2
-
4张蔷(整理),陈敏(校).有希望的新型巨细胞病毒疫苗[J].国际生物制品学杂志,2014(1):14-14.
-
5严家新,黄仕和.防治和根除狂犬病的新途径[J].生物制品快讯,2004(4):3-5.
-
6实验性疫苗与免疫刺激剂联用有望治疗HIV[J].中国处方药,2016,14(12).
-
7管洁,谭文杰.丙型肝炎病毒实验性疫苗免疫学评价[J].临床肝胆病杂志,2011,27(1):23-27. 被引量:3
-
8美研制出针对埃博拉病毒的实验性疫苗[J].中国医药导刊,2011,13(12):2102-2102.
-
9黄小琴,陈统球,谭顺革,金炜翔,阳选祥,钟光六,邵聪文.甲型肝炎灭活疫苗接种普通狨猴的安全性和免疫原性[J].中国生物制品学杂志,2000,13(1):33-35. 被引量:5
-
10张雪梅,赵红玲,王晶晶,廖芸,纳锐雄,王丽春,刘龙丁,高家红,唐东红,王从章,李琦涵.肠道病毒71型灭活疫苗在婴猴保护性实验中的病理性炎症反应[J].中华医学杂志,2011,91(28):1977-1981. 被引量:8